Expense Ratio Rating
7 /10
Expense Rating
3 /10
Market Score
9 /10
Category Score
0 /10
Market Size
9 /10
$FSMEX Alternatives
Different Funds
We found 10,815 Sector Equity Healthcare funds. Here they are ordered by FI Score.
- amrax
- Mutual Fund
- US Stocks
- Large Growth
American Growth Fund Series One Class A
Expenses: 5.44% (Better than 0% of similar funds)
This is a bad choice for a Large Growth US Stocks fund. See why »
- amrcx
- Mutual Fund
- US Stocks
- Large Growth
American Growth Fund Series One Class C
Expenses: 6.41% (Better than 0% of similar funds)
This is a bad choice for a Large Growth US Stocks fund. See why »
- apifx
- Mutual Fund
- Allocation
- All-In-One
Yorktown Master Allocation Fund Class A
Expenses: 1.62% (Better than 0% of similar funds)
This is a bad choice for a All-In-One Allocation fund. See why »
- acemx
- Mutual Fund
- International Stocks
- Emerging Markets
Alger Emerging Markets Fund Class C
Expenses: 2.28% (Better than 0% of similar funds)
This is a bad choice for a Emerging Markets International Stocks fund. See why »
- achcx
- Mutual Fund
- Bond
- High Yield Bond
American Beacon Crescent Short Duration High Income Fund C Class
Expenses: 2.00% (Better than 0% of similar funds)
This is a bad choice for a High Yield Bond Bond fund. See why »
- nubax
- Mutual Fund
- Bond
- High Yield Bond
Neuberger Berman Unconstrained Bond Fund Class A
Expenses: 1.03% (Better than 0% of similar funds)
This is a bad choice for a High Yield Bond Bond fund. See why »
- ogynx
- Mutual Fund
- Bond
- High Yield Bond
Invesco High Yield Bond Factor Fund Class R
Expenses: 1.40% (Better than 0% of similar funds)
This is a bad choice for a High Yield Bond Bond fund. See why »
- pcwcx
- Mutual Fund
- Bond
- High Yield Bond
PGIM Corporate Bond Fund- Class C
Expenses: 1.55% (Better than 0% of similar funds)
This is a bad choice for a High Yield Bond Bond fund. See why »
- amrbx
- Mutual Fund
- US Stocks
- Large Growth
American Growth Fund Series One Class B
Expenses: 8.89% (Better than 0% of similar funds)
This is a bad choice for a Large Growth US Stocks fund. See why »